The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial;Department of Error (DOI:10.1016/S0140-6736(06)69155-1)

Lancet

Volumn 368, Issue 9543, 2006, Pages 1238-

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85101728845     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(06)69155-1     Document Type: Article

References (0)